Dinesh Balachandra

Dinesh Balachandra

Auto-generated profile, based on publicly available information

Dinesh Balachandra

Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang 11800, Malaysia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2019 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MYMUHAMMAD HAFIZNUR YUNUS
MUHAMMAD HAFIZNUR YUNUS
NANORSYAHIDA ARIFIN
NORSYAHIDA ARIFIN
DBDinesh Balachandra
Dinesh Balachandra
NANor Suhada Anuar
Nor Suhada Anuar
RNRahmah Noordin
Rahmah Noordin
The conventional method of detecting Strongyloides stercoralis in fecal samples has poor diagnostic sensitivity. Detection of Strongyloides-specific antibodies increases the sensitivity; however, most tests are ELISAs that use parasite extract which may cross-react with the sera of other helminth infections. To improve the serological diagnosis of strongyloidiasis, this study aimed at developing a sensitive and specific lateral flow rapid dipstick test. Two recombinant proteins, recombinant NIE (rNIE) and recombinant Ss1a (rSs1a), were used in preparing the dipstick, with gold-conjugated antihuman IgG4 as detector reagent. In parallel, the corresponding ELISA was performed. Both assays demonstrated diagnostic sensitivity of 91.3% (21/23) when tested with serum samples of patients with Strongyloides infection, and 100% specificity with 82 sera of asymptomatic (healthy) and those with other parasitic infections. The ELISA and dipstick test results were positively correlated to each other (r = 0.6114, P = 0.0019). The developed lateral flow dipstick test may improve the serodiagnosis of strongyloidiasis and merit further validation studies.

1 September 2021 in Acta Tropica
Verified
Journal Article
Closed access
DBDinesh Balachandra
Dinesh Balachandra
ARAnizah Rahumatullah
Anizah Rahumatullah
TLTheam Soon Lim
Theam Soon Lim
FMFatin Hamimi Mustafa
Fatin Hamimi Mustafa
HAHussain Ahmad
Hussain Ahmad
RNRahmah Noordin
Rahmah Noordin

2 December 2020 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
HAHussain Ahmad
Hussain Ahmad
DBDinesh Balachandra
Dinesh Balachandra
NANORSYAHIDA ARIFIN
NORSYAHIDA ARIFIN
TNThomas J. Nolan
Thomas J. Nolan
JLJames B. Lok
James B. Lok
RNRahmah Noordin
Rahmah Noordin
Strongyloides stercoralis infection is prevalent worldwide and can cause lifelong infection in immunocompetent individuals, and potentially death in immunosuppressed patients. The diagnosis is hindered by the low sensitivity of microscopic examination, thus making serology an important complementary test to improve the detection rate. However, there were reports that some Strongyloides-infected individuals were negative with specific IgG and IgG4 assays, and other helminth infections were positive with commercial Strongyloides IgG-ELISAs. Thus, there is a need to develop better serodiagnostic methods for strongyloidiasis. We investigated the diagnostic potential of IgE-ELISAs using Strongyloides larval lysate. Sera from two groups infected with Strongyloides served as the positive reference, that is, 1) positive by commercial IgG-ELISAs and IgG4 rapid test, and stool samples positive by microscopy and/or PCR (group IA; n = 20); and 2) negative by IgG-ELISAs and IgG4 rapid test, but stool samples were PCR positive (group IB sera; n = 11). Sera from another two groups served as negative reference (controls), that is, 1) infected with other parasites (group II; n = 73) and 2) healthy donors (group III; n = 22). Results showed a 100% diagnostic sensitivity in detecting sera from groups IA and IB. The latter group of individuals probably had early infection because their IgG and IgG4 assays were negative. The optical density values of group IB sera were also significantly lower than those of group IA (P < 0.003). The IgE-ELISA was 100% specific when tested against sera from groups II and III. This study highlights the diagnostic potential of IgE-ELISA using larval lysate to detect strongyloidiasis, especially those with probable early infection.

25 October 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
ZBZamrina Baharudeen
Zamrina Baharudeen
RNRahmah Noordin
Rahmah Noordin
TLTheam Soon Lim
Theam Soon Lim
DBDinesh Balachandra
Dinesh Balachandra
NANor Suhada Anuar
Nor Suhada Anuar
ARAnizah Rahumatullah
Anizah Rahumatullah
Toxocariasis is a widespread zoonotic parasitic disease with a significant socioeconomic impact, particularly on underprivileged communities. Limitations of existing diagnostic tools and vague presenting symptoms may lead to misdiagnosis, thus underestimating the actual global impact of the disease. The present study describes the isolation and production of novel recombinant monoclonal antibodies against Toxocara canis recombinant TES-26 antigen (rTES-26) utilizing a human helminth scFv phage display library. The isolated antibody clones were characterized based on their gene sequences and binding characteristics. Three clones representing unique gene families (clone 48: IgHV3-LV1; clone 49: IgHV3-LV3; clone 50: IgHV6-LV3) were isolated, but only clones 48 and 49 showed successful insertion of the full-length scFv antibody sequence after sub-cloning. Both clones produced antibody proteins of good solubility and satisfactory yield and purity. Binding assays via Western blot and ELISA using rTES-26 and Toxocara canis native protein showed that both monoclonal antibodies were highly specific and sensitive to the target antigen. A preliminary antigen detection ELISA showed the diagnostic potential of the monoclonal antibody proteins. The proteins can also be useful in studying host–parasite interactions and therapeutic applications.